News & Insights

Gunderson Dettmer co-sponsored the Longwood Healthcare Leaders Boston CEO Summit 2025, a two-day, invitation-only conference that convenes approximately 250 biopharma CEOs, R&D executives, government officials, life science investors, and leading academics for off-the-record discussions

Join us for an Exclusive Premiere on What’s Next in Biotech with Gunderson Partner and Chair of Life Sciences Tim Ehrlich and Venrock Managing Partner Bryan Roberts

Gunderson Dettmer partner, Tim Ehrlich, to moderate a panel at the annual Genesis London Conference

Hims & Hers announces its investment in the $325 million private investment in public equity (PIPE) transaction for healthcare company GRAIL, whose mission is to detect cancer early when it can be cured

Ascenta Capital, a venture firm investing in multi-medicine development-stage biotechnology companies, announces the formation of its $325 million inaugural fund

Seven Gunderson Dettmer company clients were recognized by Forbes in its Next Billion-Dollar Startups 2025

LMG Life Sciences recognizes Gunderson Dettmer with Impact Deal of the Year and names Boston associate Joel Diamond the US Rising Star—Financial and Corporate in its 2025 Life Sciences Americas Awards

Gunderson Dettmer ranks as the most active law firm in the world for the second quarter in a row in PitchBook’s Q2 2025 Global League Tables, with 336 financings across the globe exceeding $25 billion in value